WO2001042297A3 - Proteine transmembranaire clasp-3 - Google Patents

Proteine transmembranaire clasp-3 Download PDF

Info

Publication number
WO2001042297A3
WO2001042297A3 PCT/US2000/034171 US0034171W WO0142297A3 WO 2001042297 A3 WO2001042297 A3 WO 2001042297A3 US 0034171 W US0034171 W US 0034171W WO 0142297 A3 WO0142297 A3 WO 0142297A3
Authority
WO
WIPO (PCT)
Prior art keywords
clasp
relates
transmembrane protein
polynucleotides
polypeptides
Prior art date
Application number
PCT/US2000/034171
Other languages
English (en)
Other versions
WO2001042297A2 (fr
WO2001042297A9 (fr
Inventor
Peter Lu
Jonathan David Garman
Albert Frederick Candia Iii
Original Assignee
Arbor Vita Corp
Peter Lu
Jonathan David Garman
Albert Frederick Candia Iii
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arbor Vita Corp, Peter Lu, Jonathan David Garman, Albert Frederick Candia Iii filed Critical Arbor Vita Corp
Priority to AU21076/01A priority Critical patent/AU2107601A/en
Publication of WO2001042297A2 publication Critical patent/WO2001042297A2/fr
Publication of WO2001042297A3 publication Critical patent/WO2001042297A3/fr
Publication of WO2001042297A9 publication Critical patent/WO2001042297A9/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

L'invention concerne une molécule de surface cellulaire, nommée protéine-3 d'asymétrie de type cadhérine (« CLASP-3 »). L'invention concerne notamment des polynucléotides, des polypeptides, des protéines de fusion et des anticorps de CLASP-3. L'invention concerne également des procédés de modulation d'une réponse immunologique par modification de la fonction de CLASP-3.
PCT/US2000/034171 1999-12-13 2000-12-13 Proteine transmembranaire clasp-3 WO2001042297A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU21076/01A AU2107601A (en) 1999-12-13 2000-12-13 Clasp-3 transmembrane protein

Applications Claiming Priority (24)

Application Number Priority Date Filing Date Title
US17045399P 1999-12-13 1999-12-13
US60/170,453 1999-12-13
US17619500P 2000-01-14 2000-01-14
US60/176,195 2000-01-14
US18229600P 2000-02-14 2000-02-14
US60/182,296 2000-02-14
US54727600A 2000-04-11 2000-04-11
US19652800P 2000-04-11 2000-04-11
US19646000P 2000-04-11 2000-04-11
US19626700P 2000-04-11 2000-04-11
US19652700P 2000-04-11 2000-04-11
US60/196,267 2000-04-11
US60/196,527 2000-04-11
US60/196,460 2000-04-11
US60/196,528 2000-04-11
US09/547,276 2000-04-11
US24050800P 2000-10-13 2000-10-13
US24053900P 2000-10-13 2000-10-13
US24054300P 2000-10-13 2000-10-13
US24050300P 2000-10-13 2000-10-13
US60/240,503 2000-10-13
US60/240,543 2000-10-13
US60/240,539 2000-10-13
US60/240,508 2000-10-13

Publications (3)

Publication Number Publication Date
WO2001042297A2 WO2001042297A2 (fr) 2001-06-14
WO2001042297A3 true WO2001042297A3 (fr) 2002-01-03
WO2001042297A9 WO2001042297A9 (fr) 2002-07-25

Family

ID=27583776

Family Applications (3)

Application Number Title Priority Date Filing Date
PCT/US2000/034171 WO2001042297A2 (fr) 1999-12-13 2000-12-13 Proteine transmembranaire clasp-3
PCT/US2000/034163 WO2001042296A2 (fr) 1999-12-13 2000-12-13 Proteine transmembranaire de clasp-5
PCT/US2000/034152 WO2001042295A2 (fr) 1999-12-13 2000-12-13 Proteine transmembranaire clasp-7

Family Applications After (2)

Application Number Title Priority Date Filing Date
PCT/US2000/034163 WO2001042296A2 (fr) 1999-12-13 2000-12-13 Proteine transmembranaire de clasp-5
PCT/US2000/034152 WO2001042295A2 (fr) 1999-12-13 2000-12-13 Proteine transmembranaire clasp-7

Country Status (3)

Country Link
EP (1) EP1238078A2 (fr)
AU (4) AU2269701A (fr)
WO (3) WO2001042297A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2618974C (fr) 2005-08-09 2014-01-28 Nanobio Corporation Compositions de nanoemulsions possedant une activite anti-inflammatoire
JP6990522B2 (ja) * 2017-04-11 2022-02-03 シスメックス株式会社 免疫細胞の免疫刺激応答性を測定する方法、免疫細胞における免疫シナプスの形成能を判定する方法及び細胞分析装置

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000020434A1 (fr) * 1998-10-02 2000-04-13 The Board Of Trustees Of The Leland Stanford Junior University Proteine-1 d'asymetrie analogue a la cadherine, et ses procedes d'utilisation

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000020434A1 (fr) * 1998-10-02 2000-04-13 The Board Of Trustees Of The Leland Stanford Junior University Proteine-1 d'asymetrie analogue a la cadherine, et ses procedes d'utilisation

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
. HILLIER ET AL: "generation and analysis of 280,000 human expressed sequence tags", GENERATION AND ANALYSIS OF 280,000 GENOME RESEARCH, vol. 6, no. 9, September 1996 (1996-09-01), pages 807 - 828, XP002140684 *
DATABASE EMBL 14 October 2000 (2000-10-14), NIH-MGC: "601459988f1 NIH-MGC-66 Homo sapiens cDNA clone IMAGE:3863661 5'", XP002167755 *
DATABASE EMBL 25 May 1997 (1997-05-25), L. HILLIER ET AL: "The WashU merck EST project 1997", XP002167752 *
DATABASE EMBL 27 December 1996 (1996-12-27), L. HILLIER ET AL: "zp19h01.s1 Stratagene fetal retina 937202 Homo sapiens cDNA clone IMAGE:609937 3', mRNA sequence", XP002167753 *
DATABASE EMBL 7 February 2001 (2001-02-07), O. OHARA ET AL: "Homo sapiens mRNA for KIAA1771 protein, partial cds", XP002167754 *
T. NAGASE ET AL: "Prediction of the coding sequences of 100 new cDNA clones from brain which code for large proteins in vitro", DNA RESEARCH, vol. 7, 2000, pages 347 - 355 *
UNPUBLISHED *

Also Published As

Publication number Publication date
WO2001042297A2 (fr) 2001-06-14
WO2001042296A3 (fr) 2002-05-10
WO2001042296A2 (fr) 2001-06-14
WO2001042295A2 (fr) 2001-06-14
AU2107601A (en) 2001-06-18
EP1238078A2 (fr) 2002-09-11
AU2107401A (en) 2001-06-18
WO2001042295A3 (fr) 2002-03-21
WO2001042297A9 (fr) 2002-07-25
AU2270201A (en) 2001-06-18
AU2269701A (en) 2001-06-18

Similar Documents

Publication Publication Date Title
CA2155185A1 (fr) Reactifs par affinite, totalement synthetiques
WO2001094413A3 (fr) Acides nucleiques et polypeptides apparentes a b7 utiles pour effectuer une immunomodulation
EP1304382A3 (fr) Production de peptides dans des végétaux par fusions de protéines d'enveloppes virales
WO2000053722A3 (fr) Administration de substances a des cellules
AU4639396A (en) Cytokine designated lerk-7
WO2004020404A3 (fr) Proteines hybrides de la transferrine-anticorps modifiees
HK1036475A1 (en) Erythropoietin analog-human serum albumin fusion protein
WO2002002627A3 (fr) Proteine zcyto21de type interferon
WO2002062999A8 (fr) Proteines et acides nucleiques codant pour celles-ci
WO1996009386A3 (fr) Variantes alleliques du recepteur 5ht2c de la serotonine
WO2002046409A3 (fr) Proteines et acides nucleiques les codant
WO1995027059A1 (fr) L'afamine, une proteine albuminoide serique humaine
WO2002059315A3 (fr) Nouveaux acides nucleiques et polypeptides et procedes de leur utilisation
WO2000061747A3 (fr) Proteines transmembranaires clasp-2
WO2001094949A3 (fr) Compositions solubles a base de cd1 et leurs utilisations
WO2001042297A3 (fr) Proteine transmembranaire clasp-3
WO2002031117A3 (fr) Proteines transmembranaires clasp-2
WO2002085922A3 (fr) Proteines et acides nucleiques codant pour celles-ci
JP2000236877A5 (fr)
WO2001042294A3 (fr) Proteine transmembranaire clasp-4
AU2486900A (en) Rubredoxin fusion proteins, protein expression system and methods
WO2001085908A9 (fr) Proteine transmembranaire clasp-1
EP0885959A3 (fr) Protéine Wnt-5b humaine
WO2003025120A3 (fr) Proteines des membranes de type clasp
EP1892251A3 (fr) Acides nucléiques et polypeptides apparentés à B7 utiles pour effectuer une immunomodulation

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US US US US US US US US US US US US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US US US US US US US US US US US US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

AK Designated states

Kind code of ref document: C2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US US US US US US US US US US US US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: C2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

COP Corrected version of pamphlet

Free format text: PAGES 1/64-64/64, DRAWINGS, REPLACED BY NEW PAGES 1/62-62/62; DUE TO LATE TRANSMITTAL BY THE RECEIVING OFFICE

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP